Infantile Marfan syndrome in a Korean tertiary referral center

다국어 초록 (Multilingual Abstract)

Purpose: Infantile Marfan syndrome (MFS) is a rare congenital inheritable connective tissue disorder with poor prognosis. This study aimed to evaluate the cardiovascular manifestations and overall prognosis of infantile MFS diagnosed in a tertiary referral center in Korea.
Methods: Eight patients diagnosed with infantile MFS between 2004 and 2014 were retrospectively evaluated.
Results: Their median age at the time of diagnosis was 2.5 months (range, 0–20 months). The median follow-up period was 25.5 months (range, 0–94 months). The median length at birth was 50.0 cm (range, 48–53 cm); however, height became more prominent over time, and the patients were taller than the 97th percentile at the time of the study. None of the patients had any relevant family history. Four of the 5 patients who underwent DNA sequencing had a fibrillin 1 gene mutation. All the patients with echocardiographic data of the aortic root had a z score of >2. All had mitral and tricuspid valve prolapse, and various degrees of mitral and tricuspid regurgitation. Five patients underwent open-heart surgery, including mitral valve replacement, of whom two required multiple operations. The median age at mitral valve replacement was 28.5 months (range, 5–69 months). Seven patients showed congestive heart failure before surgery or during follow-up, and required multiple anti-heart failure medications. Four patients died of heart failure at a median age of 12 months.
Conclusion: The prognosis of infantile MFS is poor; thus, early diagnosis and timely cautious treatment are essential to prevent further morbidity and mortality.

참고문헌 (Reference)

1 Marfan AB, "Uncas de déformationcongénitale des quatremembres, plus prononcée aux extrémités, caractériséeparl'allongement des os avec un certaindegréd'amincissement" 13 : 220-226, 1896

2 Geva T, "Two-dimensional and Doppler echocardiographic and pathologic characteristics of the infantile Marfan syndrome" 65 : 1230-1237, 1990

3 Loeys BL, "The revised Ghent nosology for the Marfan syndrome" 47 : 476-485, 2010

4 김응래, "Surgical Management of Mitral Regurgitation in Patients with Marfan Syndrome during Infancy and Early Childhood" 대한흉부외과학회 48 (48): 7-12, 2015

5 Miyahara Y, "Successful aortic reimplantation in a three-year-old child with Marfan syndrome" 11 : 218-220, 2010

6 Shinawi M, "Splicing mutation in the fibrillin-1 gene associated with neonatal Marfan syndrome and severe pulmonary emphysema with tracheobronchomalacia" 39 : 374-378, 2005

7 Hennekam RC, "Severe infantile Marfan syndrome versus neonatal Marfan syndrome" 139 : 1-, 2005

8 De Paepe A, "Revised diagnostic criteria for the Marfan syndrome" 62 : 417-426, 1996

9 Pearson GD, "Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders" 118 : 785-791, 2008

10 Strigl S, "Quadrivalvar replacement in infantile Marfan syndrome" 28 : 403-405, 2007

11 Day DL, "Pulmonary emphysema in a neonate with Marfan syndrome" 16 : 518-521, 1986

12 Sutherell J, "Novel fibrillin 1 mutation in a case of neonatal Marfan syndrome: the increasing importance of early recognition" 2 : 342-346, 2007

13 Buchhorn R, "Neonatal Marfan syndrome: improving the bad prognosis with a strict conservative treatment with carvedilol?" 4 : 44-47, 2014

14 Das R, "Neonatal Marfan syndrome: a rare presentation" 12 : 57-59, 2015

15 Shih HY, "Neonatal Marfan syndrome: a case report" 20 : 171-175, 2004

16 Ramaswamy P, "Neonatal Marfan syndrome : in utero presentation with aortic and pulmonary artery dilatation and successful repair of an acute flail mitral valve leaflet in infancy" 27 : 763-765, 2006

17 Pyeritz RE, "Mitral valve dysfunction in the Marfan syndrome. Clinical and echocardiographic study of prevalence and natural history" 74 : 797-807, 1983

18 Keane MG, "Medical management of Marfan syndrome" 117 : 2802-2813, 2008

19 Judge DP, "Marfan's syndrome" 366 : 1965-1976, 2005

20 Canadas V, "Marfan syndrome. Part 2: treatment and management of patients" 7 : 266-276, 2010

21 Cañadas V, "Marfan syndrome. Part 1: pathophysiology and diagnosis" 7 : 256-265, 2010

22 Dietz HC, "Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene" 352 : 337-339, 1991

23 Beighton P, "International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986" 29 : 581-594, 1988

24 Erkula G, "Growth and maturation in Marfan syndrome" 109 : 100-115, 2002

25 Morse RP, "Diagnosis and management of infantile marfan syndrome" 86 : 888-895, 1990

26 Phornphutkul C, "Cardiac manifestations of Marfan syndrome in infancy and childhood" 47 : 587-596, 1973

27 Lacro RV, "Atenolol versus losartan in children and young adults with Marfan's syndrome" 371 : 2061-2071, 2014

28 van Kimmenade RR, "A clinical appraisal of different Z-score equations for aortic root assessment in the diagnostic evaluation of Marfan syndrome" 15 : 528-532, 2013